We are live on ! Find out more
MEDP icon

Medpace
MEDP

77 hedge funds and large institutions have $197M invested in Medpace in 2017 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 26 increasing their positions, 20 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

30% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 20

24% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 21

1.57% less ownership

Funds ownership: 17.83% → 16.25% (-1.6%)

3% less funds holding

Funds holding: 79 → 77 (-2)

25% less capital invested

Capital invested by funds: $262M → $197M (-$64.6M)

Holders
77
Holders Change
-2
Holders Change %
-2.53%
% of All Funds
1.92%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
26
Increased
26
Reduced
20
Closed
21
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$18.8M
2
Capital Research Global Investors
Capital Research Global Investors
California
+$12.2M
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$10.7M
4
HM
HealthCor Management
New York
+$8.88M
5
BCA
Bernzott Capital Advisors
California
+$7.94M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$15.8M
2
BAMCO Inc
BAMCO Inc
New York
-$15.2M
3
Wellington Management Group
Wellington Management Group
Massachusetts
-$12.5M
4
FA
Friess Associates
Delaware
-$9.25M
5
O
OppenheimerFunds
New York
-$9.19M
Name Holding Trade Value Shares
Change 		Change in
Stake
AIM
76
Advantage Investment Management
Iowa
$1K +$1.13K +35 New
Walleye Trading
77
Walleye Trading
New York
$382 +$67.8K +2,100 +20%
Wellington Management Group
78
Wellington Management Group
Massachusetts
– -$12.5M -346,623 Closed
FA
79
Friess Associates
Delaware
– -$9.25M -256,326 Closed
O
80
OppenheimerFunds
New York
– -$9.19M -254,730 Closed
NCGI
81
Next Century Growth Investors
Minnesota
– -$5.72M -158,476 Closed
RSCM
82
Rock Springs Capital Management
Maryland
– -$4.87M -135,000 Closed
JP Morgan Chase
83
JP Morgan Chase
New York
– -$1.75M -48,600 Closed
JHIU
84
Janus Henderson Investors US
Colorado
– -$1.67M -46,172 Closed
MIM
85
Monashee Investment Management
Massachusetts
– -$1.02M -28,324 Closed
First Trust Advisors
86
First Trust Advisors
Illinois
– -$870K -24,120 Closed
LCG
87
Lisanti Capital Growth
New York
– -$703K -19,481 Closed
Two Sigma Advisers
88
Two Sigma Advisers
New York
– -$458K -12,700 Closed
BIM
89
Bogle Investment Management
Massachusetts
– -$424K -11,772 Closed
GCP
90
GSA Capital Partners
United Kingdom
– -$338K -9,370 Closed
IR
91
Invictus RG
Bermuda
– -$335K -9,297 Closed
RJFSA
92
Raymond James Financial Services Advisors
Florida
– -$267K -7,400 Closed
GPCM
93
Granite Point Capital Management
Massachusetts
– -$243K -6,750 Closed
USAA
94
United Services Automobile Association
Texas
– -$233K -6,470 Closed
CSS
95
Cubist Systematic Strategies
Connecticut
– -$227K -6,304 Closed
Squarepoint
96
Squarepoint
New York
– -$227K -6,300 Closed
PPA
97
Parametric Portfolio Associates
Washington
– -$220K -6,110 Closed
Creative Planning
98
Creative Planning
Kansas
– -$1K -32 Closed
1 2 3
4

MEDP Hedge Fund Activity: Q1 2017 in Review

77 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Medpace (MEDP) for Q1 2017, worth a combined $197M — down 25% from $262M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new MEDP positions and 21 closed out — a net gain of 5 holders — while 26 added to existing stakes and 20 trimmed.

The largest buyer was BlackRock, adding an estimated $18.8M. The largest seller was Fidelity Investments, cutting an estimated $15.8M.

  • 77 institutional investors held Medpace (MEDP) as of Q1 2017, down from 79 in Q4 2016.
  • Funds reported $197M of Medpace stock for Q1 2017, down 25% quarter-over-quarter.
  • 26 funds opened new Medpace positions in Q1 2017 and 21 closed out, a net change of +5 holders.
  • The largest Medpace buyer in Q1 2017 was BlackRock, an estimated $18.8M added.
  • The largest Medpace seller in Q1 2017 was Fidelity Investments, an estimated $15.8M sold.

Based on aggregated 13F filings for Q1 2017.